Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice
Author(s) -
Mizuho HiramatsuIto,
Rei Shibata,
Koji Ohashi,
Yusuke Uemura,
Noriyoshi Kanemura,
Takahiro Kambara,
Takashi Enomoto,
Daisuke Yuasa,
Kazuhiro Matsuo,
Masanori Ito,
Satoko Hayakawa,
Hayato Ogawa,
Naoya Otaka,
Shinji Kihara,
Toyoaki Murohara,
Noriyuki Ouchi
Publication year - 2015
Publication title -
cardiovascular research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvv282
Subject(s) - apolipoprotein b , lesion , apolipoprotein e , medicine , endocrinology , cardiology , pathology , cholesterol , disease
Obesity is associated with the development of atherosclerosis. We previously demonstrated that omentin is a circulating adipokine that is downregulated in association with atherosclerotic diseases. Here, we examined the impact of omentin on the development of atherosclerosis with gain-of-function genetic manipulations and dissected its potential mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom